Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Carcinoma, Renal Cell 2Pelvic Neoplasms 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Abdominal Neoplasms 1

Interventions

Specimen Handling 2Radiotherapy 2Iohexol 2Gemcitabine 2spartalizumab 1sodium thiosulfate 1liposomal doxorubicin 1X-Rays 1Vorinostat 1Surgical Procedures, Operative 1Sunitinib 1Solutions 1Saline Solution 1Re-Irradiation 1Radiotherapy, Image-Guided 1Radiosurgery 1Probiotics 1Platinum 1Particle Accelerators 1Pafolacianine 1Paclitaxel 1Magnetic Resonance Spectroscopy 1Magnetic Resonance Imaging 1Lidocaine 1Ketamine 1Injections 1Immunotherapy, Adoptive 1Hyperthermic Intraperitoneal Chemotherapy 1FS 069 1Embolization, Therapeutic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Pelvic Neoplasms × FS 069 × Clear all
NCT00186953 2011-09-20

Determination of a Safe Dose of Optison in Pediatric Patients With Solid Tumors

St. Jude Children's Research Hospital

Phase 1 Completed
14 enrolled
Gynecologic

Abdominal Neoplasms, Pelvic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡